Neurology News and Research

Latest Neurology News and Research

Scientists characterize new genetic variants that cause nonsyndromic neurodevelopmental disorder

Northwestern Medicine scientists have characterized several variants of the gene GRIK2 that cause nonsyndromic neurodevelopmental disorder (NDD), according to a study published in the American Journal of Human Genetics.

23 Sep 2021

Discovery points toward a new strategy for treating Parkinson's disease

University of Utah Health scientists have identified a molecule that slows cells' production of alpha-synuclein, a protein that forms toxic aggregates in the brains of people with Parkinson's disease.

23 Sep 2021

Study provides clearer understanding of how migraines affect sleep patterns

Adults and children with migraines may get less quality, REM sleep time than people who don't have migraines.

23 Sep 2021

Naturally occurring protein associated with better stroke recovery in mice

A naturally occurring protein that blocks an inflammatory immune response was associated with better stroke recovery in a study conducted in mice, according to preliminary research to be presented at the American Heart Association's Vascular Discovery: From Genes to Medicine Scientific Sessions 2021.

23 Sep 2021

SARS-CoV-2 infection may prompt Guillain-Barré syndrome

A new paper in Brain, published by Oxford University Press, indicates that a COVID-19 infection may prompt Guillain-Barré syndrome.

23 Sep 2021

People with neurologic conditions more likely to have had adverse childhood experiences

Adults with neurologic conditions are more likely than the general population to have had adverse childhood experiences such as abuse, neglect or household dysfunction, according to a study published in the September 22, 2021, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.

22 Sep 2021

Discovery points toward a new strategy for treating Parkinson’s disease

University of Utah Health scientists have identified a molecule that slows cells’ production of alpha-synuclein, a protein that forms toxic aggregates in the brains of people with Parkinson’s disease.

21 Sep 2021

Nasal drugs show success in slowing Parkinson's disease progression in mice

Potential new treatments for Parkinson's disease developed by researchers at Rush University Medical Center have shown success in slowing progression of the disease in mice.

21 Sep 2021

Clinical trial reveals optimal period for intensive rehabilitation of arm and hand use after stroke

A phase II, randomized clinical trial found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should begin 60 to 90 days after the event.

21 Sep 2021

Study reveals brain insult from hypertension among middle-aged adults

Hypertension that leads to vascular dementia in older adults begins to impact the brain by middle age, reports a large new Northwestern Medicine study published in PNAS, the first to show the process begins so early.

20 Sep 2021

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

To coincide with World Alzheimer’s Month, EIT Health, an EU-backed network of best-in-class health innovators, has highlighted the urgent need to focus on implementing bolder approaches to the treatment of Alzheimer’s Disease post-pandemic.

20 Sep 2021

Brain scans can help estimate the time when a person will start showing signs of dementia

Researchers at Washington University School of Medicine in St. Louis have developed an approach to estimating when a person with no cognitive symptoms will start showing signs of Alzheimer's dementia based on data from brain scans and the person's age.

16 Sep 2021

UTSW researchers discover how vitamin A enters immune cells in the intestines

Immunologists and geneticists at UT Southwestern Medical Center have discovered how vitamin A enters immune cells in the intestines – findings that could offer insight to treat digestive diseases and perhaps help improve the efficacy of some vaccines.

16 Sep 2021

MS patients diagnosed with colorectal cancer may have shorter survival times, study finds

People with multiple sclerosis (MS) who are diagnosed with colorectal cancer may be at a higher risk of dying from cancer or other causes over the next six months to one year than people with colorectal cancer who do not have MS, according to a study published in the September 15, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Sep 2021

Albert Einstein College of Medicine receives $5 million NIH grant for IDD research

Albert Einstein College of Medicine has received a five-year, $5 million grant from the National Institutes of Health to support the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, which has been at the forefront of research on normal and abnormal brain development for more than 50 years.

15 Sep 2021

Researchers disprove natural antioxidant urate for slowing the progression of Parkinson’s disease

The hypothesis that raising the brain levels of the natural antioxidant urate could slow the progression of Parkinson's disease (PD) has been disproven by researchers at Massachusetts General Hospital.

14 Sep 2021

Blood lipid biomarkers associated with lower risk of ALS

Some blood lipid biomarkers linked to cardiovascular disease risk are also associated with a lower risk of amyotrophic lateral sclerosis (ALS) suggest the findings of a large epidemiology study published online in the Journal of Neurology Neurosurgery & Psychiatry.

14 Sep 2021

Rutgers study examines link between COVID-19 and memory loss, dementia

A new Rutgers study will examine how COVID-19 is affecting individuals in a number of cognitive-related areas, including memory loss, "brain fog," and dementia.

13 Sep 2021

Emotional support and resilience can help mitigate the psychological effects of the pandemic

Health care workers with high resilience or strong emotional support were protected against the effects of stress related to the COVID-19 pandemic compared to those who had low emotional support or resilience, according to a study published September 13 in the Journal of Medical Internet Research.

13 Sep 2021

USC Stevens INI launches a $3 million study to solve some puzzles about Parkinson's disease

The USC Mark and Mary Stevens Neuroimaging and Informatics Institute (USC Stevens INI), part of the Keck School of Medicine of USC, has launched a $3 million study that will unite researchers and data from 20 countries to answer some of the most pressing questions about Parkinson's disease (PD).

11 Sep 2021

Neurology News and Research

Latest Neurology News and Research

Scientists characterize new genetic variants that cause nonsyndromic neurodevelopmental disorder

Discovery points toward a new strategy for treating Parkinson's disease

Study provides clearer understanding of how migraines affect sleep patterns

Naturally occurring protein associated with better stroke recovery in mice

SARS-CoV-2 infection may prompt Guillain-Barré syndrome

People with neurologic conditions more likely to have had adverse childhood experiences

Discovery points toward a new strategy for treating Parkinson’s disease

Nasal drugs show success in slowing Parkinson's disease progression in mice

Clinical trial reveals optimal period for intensive rehabilitation of arm and hand use after stroke

Study reveals brain insult from hypertension among middle-aged adults

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

Brain scans can help estimate the time when a person will start showing signs of dementia

UTSW researchers discover how vitamin A enters immune cells in the intestines

MS patients diagnosed with colorectal cancer may have shorter survival times, study finds

Albert Einstein College of Medicine receives $5 million NIH grant for IDD research

Researchers disprove natural antioxidant urate for slowing the progression of Parkinson’s disease

Blood lipid biomarkers associated with lower risk of ALS

Rutgers study examines link between COVID-19 and memory loss, dementia

Emotional support and resilience can help mitigate the psychological effects of the pandemic

USC Stevens INI launches a $3 million study to solve some puzzles about Parkinson's disease

Everything you need to know about epilepsy eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Neurology News and Research

Latest Neurology News and Research

Everything you need to know about epilepsy eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in